Metraipolis › archive › dc_fcaf69eab700
Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2-Positive… — Europe PMC PMID:42214048
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42214048
- DOI
- 10.1200/go-25-00287
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-15T17:19:16.913Z
- SHA-256 of the archived text
566e3391ec00a9ff46aea0d16a027fb2efaae38cd0523b4d684d4cda689aa71a- Stable URL of this page
https://metraipolis.com/documento/dc_fcaf69eab700
How to cite
Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2-Positive… — Europe PMC PMID:42214048 — Europe PMC (en), https://europepmc.org/article/MED/42214048 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fcaf69eab700 (Metraipolis archive dc_fcaf69eab700, sha256 566e3391ec00a9ff46aea0d16a027fb2efaae38cd0523b4d684d4cda689aa71a)
BibTeX
@misc{dcfcaf69eab700,
title = {Pragmatic Clinical Trial Assessing Response to Neoadjuvant Docetaxel and Trastuzumab in Nigerian Women With Human Epidermal Growth Factor Receptor 2-Positive… — Europe PMC PMID:42214048},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42214048},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fcaf69eab700; sha256 566e3391ec00a9ff46aea0d16a027fb2efaae38cd0523b4d684d4cda689aa71a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42214048. Agents can read the archived copy with the MCP tool read_document.